岛津企业管理(中国)有限公司/岛津(香港)有限公司
400-6699-1176666

分析测试百科网 认证会员,请放心拨打!

分析测试百科网 > 岛津 > 新闻动态 > 欢迎阅读最新一期《SHIMADZU JOURNAL》
皇冠会员

诚信认证:

工商注册信息已核实!
为了庆祝岛津制作所创业140周年,岛津在“逐梦科学140载 厚积薄发 共创未来”......
 “十二五”期间,中国将把农村饮水安全工程作为社会主义新农村建设的重点内容之一,......
扫一扫即可访问手机版展台

欢迎阅读最新一期《SHIMADZU JOURNAL》

发布时间: 2015-12-22 00:00 来源:岛津企业管理(中国)有限公司/岛津(香港)有限公司

SHIMADZU JOURNAL 

The Current Issue

Vol.3, Issue3-June 2015

Vol.3, Issue3-Dec 2015

(http://www.shimadzu.com/an/journal/content_vol3_iss3.html)

岛津制作所分析计测事业部新任总监Shuzo Maruyama在本期杂志做了首秀。希望您喜欢我们新改版的Shimadzu Journal
    本期关注药物分析。专题文章之一是关于与威斯康星大学密尔沃基研究所亚历山大·阿诺德副教授在新药研发上的合作。另一篇文章讨论了与日本三菱田边制药公司的合作,使用成像质谱质谱显微镜iMScope TRIO进行药品研发。

此外,本期还包括一些其他领域的信息以及最新消息和应用。

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img01_1.jpg[Insight from Customer]

Professor Alexander (Leggy) Arnold from Milwaukee Institute for Drug Discovery (160KB)

We interviewed Dr. Arnold, aka Leggy Arnold, an Associate Professor in the Department of Chemistry and Biochemistry, Principle Investigator of the Shimadzu Laboratory for Advanced and Applied Analytical Chemistry and Founding Member of the Milwaukee Institute for Drug Discovery (MIDD) at the University of Wisconsin-Milwaukee (UWM).

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img02_1.jpg

[Drug Discovery]

Metabolic Studies of Drug Candidates for Neurological Disorders and Asthma Based on GABAA Receptor Subtype Selective Ligands using Mass Spectrometry (312KB)

Development of pre-clinical experimental models to understand the in vivo metabolic performance of a drug is important in the field of drug discovery. In the present study, an in vitro microsomal assay was designed to evaluate the metabolic stability of GABAA receptor subtype selective ligands using microsomes and S9 fractions of human and mouse liver extracts. A LC-MS/MS method was developed to quantify the amount of drug degrading over a period of time using verapamil as internal standard.

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img03_1.jpg

[Interview]

The Challenge of Discovery and Development of Pharmaceutical Products Using Imaging Mass Spectrometry: iMScope TRIO (182KB)

Imaging mass spectrometry (IMS), which uses MALDI-TOF/MS analysis to identify the presence of target substances in biosamples such as tissue samples, is a cutting-edge measurement technology that is becoming increasingly popular in medical and biological research. We sat down with Hidefumi Kaji, PhD, of Mitsubishi Tanabe Pharma Corporation’s DMPK (Drug Metabolism and Pharmacokinetics) Research Laboratories Research Division, and asked him about his use of this technology.

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img04.jpg

[Drug Discovery]

Utility of High-resolution MALDI imaging in Drug Discovery: Histological Distribution of Gentamicin in Proximal Renal Tubules of Rats (556KB)

MS/MS imaging of gentamicin was performed from high-selectivity analysis of endogenous metabolites in biological tissue.High-resolution (10 μm) imaging of rat renal cortex showed that gentamicin is specifically distributed in proximal renal tubules. A new matrix application method is useful for sensitive MALDI imaging.

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img05_1.jpg

Posters from Recent Conferences (128KB)

These articles were selected by Shimadzu. Relating to pharmaceutical analysis, they are from posters presented at recent international conferences in 2015, such as ASMS and HPLC. They feature a variety of instruments we produce and include cutting-edge technologies.

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img06_1.jpg

[Topics]

Renovated Showroom for Analytical & Measuring Instruments Newly Opened “Science Plaza” (99KB)

Shimadzu Corporation has renovated its showroom for analytical & measuring instruments at its headquarters and opened a new facility called “Science Plaza”.

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img07_1.jpg

[Topics]

Design Awards in 2015 (64KB)

Shimadzu wins two design awards this year.

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img08.jpg

[Topics]

SHIMADZU TECH TOUR at WCMic 2015 (143KB)

Shimadzu held a TECH TOUR at the 10th World Congress for Microcirculation and about 140 attendees from all over the world joined it.

http://www.shimadzu.com/an/journal/n9j25k00000nmp4f-img/img09_1.jpg

[New Products]

LCMS-8060, Py-Screener (Py-GC/MS Screening System for Phthalate Esters), AOC-6000 (Autosampler for GCMS) (184KB)


关于岛津

   岛津企业管理(中国)有限公司是(株)岛津制作所于1999年100%出资,在中国设立的现地法人公司,在中国全境拥有13个分公司,事业规模不断扩大。其下设有北京、上海、广州、沈阳、成都分析中心,并拥有覆盖全国30个省的销售代理商网络以及60多个技术服务站,已构筑起为广大用户提供良好服务的完整体系。本公司以“为了人类和地球的健康”为经营理念,始终致力于为用户提供更加先进的产品和更加满意的服务,为中国社会的进步贡献力量。

更多信息请关注岛津公司网站www.shimadzu.com.cn/an/

岛津官方微博地址http://weibo.com/chinashimadzu

7e2e5f4e-9a90-4dff-9563-ceba4dac6fa3

岛津微信平台

标签:岛津 SHIMADZU JOURNAL
移动版: 资讯 直播 仪器谱

Copyright ©2007-2024 ANTPEDIA, All Rights Reserved

京ICP备07018254号 京公网安备1101085018 电信与信息服务业务经营许可证:京ICP证110310号